US Food and Drug Administration Approval of Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis: A Model for Orphan Drug Development.
Pearson
RD
Box 485, Division of Geographic and International Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA.
Jeronimo
SM
Lareau
SM